Griewank KG - Search Results

1

Evaluation of a Deep Learning Approach to Differentiate Bowen's Disease and Seborrheic Keratosis.

Jansen P, Baguer DO, Duschner N, Le'Clerc Arrastia J, Schmidt M, Wiepjes B, Schadendorf D, Hadaschik E, Maass P, Schaller J, Griewank KG. Jansen P, et al. Among authors: griewank kg. Cancers (Basel). 2022 Jul 20;14(14):3518. doi: 10.3390/cancers14143518. Cancers (Basel). 2022. PMID: 35884578 Free PMC article.

2

New developments in biomarkers for melanoma.

Griewank KG, Ugurel S, Schadendorf D, Paschen A. Griewank KG, et al. Curr Opin Oncol. 2013 Mar;25(2):145-51. doi: 10.1097/CCO.0b013e32835dafdf. Curr Opin Oncol. 2013. PMID: 23334230 Review.

3

Vemurafenib reverses immunosuppression by myeloid derived suppressor cells.

Schilling B, Sucker A, Griewank K, Zhao F, Weide B, Görgens A, Giebel B, Schadendorf D, Paschen A. Schilling B, et al. Int J Cancer. 2013 Oct 1;133(7):1653-63. doi: 10.1002/ijc.28168. Epub 2013 Apr 13. Int J Cancer. 2013. PMID: 23526263

4

Lack of SF3B1 R625 mutations in cutaneous melanoma.

Schilling B, Bielefeld N, Sucker A, Hillen U, Zimmer L, Schadendorf D, Zeschnigk M, Griewank KG. Schilling B, et al. Among authors: griewank kg. Diagn Pathol. 2013 May 21;8:87. doi: 10.1186/1746-1596-8-87. Diagn Pathol. 2013. PMID: 23694694 Free PMC article.

5

Tumor regression and sirolimus-based therapy in lung transplantation.

Hillen U, Griewank K, Sommerwerck U, Baba HA, Schadendorf D. Hillen U, et al. J Heart Lung Transplant. 2013 Sep;32(9):938-9. doi: 10.1016/j.healun.2013.06.022. J Heart Lung Transplant. 2013. PMID: 23953823 No abstract available.

6

TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas.

Griewank KG, Schilling B, Murali R, Bielefeld N, Schwamborn M, Sucker A, Zimmer L, Hillen U, Schaller J, Brenn T, Schadendorf D, Mentzel T. Griewank KG, et al. Mod Pathol. 2014 Apr;27(4):502-8. doi: 10.1038/modpathol.2013.168. Epub 2013 Sep 13. Mod Pathol. 2014. PMID: 24030750 Free article.

7

Combination of BRAF Inhibitors and Brain Radiotherapy in Patients With Metastatic Melanoma Shows Minimal Acute Toxicity.

Rompoti N, Schilling B, Livingstone E, Griewank K, Hillen U, Sauerwein W, Pöttgen C, Stuschke M, Schadendorf D, Zimmer L. Rompoti N, et al. J Clin Oncol. 2013 Oct 20;31(30):3844-5. doi: 10.1200/JCO.2013.50.8473. Epub 2013 Sep 23. J Clin Oncol. 2013. PMID: 24062392 No abstract available.

8

Conjunctival melanomas harbor BRAF and NRAS mutations--response.

Griewank KG, Westekemper H, Schilling B, Livingstone E, Schimming T, Sucker A, Hillen U, Steuhl KP, Zimmer L, Schadendorf D. Griewank KG, et al. Clin Cancer Res. 2013 Nov 15;19(22):6331-2. doi: 10.1158/1078-0432.CCR-13-2368. Epub 2013 Oct 29. Clin Cancer Res. 2013. PMID: 24170549 No abstract available.

9

TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma.

Griewank KG, Murali R, Schilling B, Schimming T, Möller I, Moll I, Schwamborn M, Sucker A, Zimmer L, Schadendorf D, Hillen U. Griewank KG, et al. PLoS One. 2013 Nov 18;8(11):e80354. doi: 10.1371/journal.pone.0080354. eCollection 2013. PLoS One. 2013. PMID: 24260374 Free PMC article.

10

Genetic alterations and personalized medicine in melanoma: progress and future prospects.

Griewank KG, Scolyer RA, Thompson JF, Flaherty KT, Schadendorf D, Murali R. Griewank KG, et al. J Natl Cancer Inst. 2014 Feb;106(2):djt435. doi: 10.1093/jnci/djt435. J Natl Cancer Inst. 2014. PMID: 24511108 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters